🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
16.73
+0.11 (0.66%)
Nov 20, 2026, 9:49 AM EST - Market open

Xeris Biopharma Holdings Statistics

Total Valuation

XERS has a market cap or net worth of $3.06 billion. The enterprise value is $3.15 billion.

Market Cap3.06B
Enterprise Value 3.15B

Important Dates

The last earnings date was Thursday, November 5, 2026, before market open.

Earnings Date Nov 5, 2026
Ex-Dividend Date n/a

Share Statistics

XERS has 182.70 million shares outstanding. The number of shares has increased by 10.49% in one year.

Current Share Class 182.70M
Shares Outstanding 182.70M
Shares Change (YoY) +10.49%
Shares Change (QoQ) +9.89%
Owned by Insiders (%) 3.38%
Owned by Institutions (%) 61.76%
Float 176.52M

Valuation Ratios

PE Ratio n/a
Forward PE 51.81
PS Ratio 8.25
Forward PS 6.55
PB Ratio 62.20
P/TBV Ratio n/a
P/FCF Ratio 41.81
P/OCF Ratio 41.23
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 53.13, with an EV/FCF ratio of 43.12.

EV / Earnings n/a
EV / Sales 8.50
EV / EBITDA 53.13
EV / EBIT 66.94
EV / FCF 43.12

Financial Position

The company has a current ratio of 2.15, with a Debt / Equity ratio of 4.63.

Current Ratio 2.15
Quick Ratio 1.48
Debt / Equity 4.63
Debt / EBITDA 3.37
Debt / FCF 3.11
Interest Coverage 1.70

Financial Efficiency

Return on equity (ROE) is -27.11% and return on invested capital (ROIC) is 11.00%.

Return on Equity (ROE) -27.11%
Return on Assets (ROA) 7.37%
Return on Invested Capital (ROIC) 11.00%
Return on Capital Employed (ROCE) 16.20%
Weighted Average Cost of Capital (WACC) 8.91%
Revenue Per Employee $846,572
Profits Per Employee -$14,933
Employee Count435
Asset Turnover 0.93
Inventory Turnover 0.64

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +135.12% in the last 52 weeks. The beta is 0.84, so XERS's price volatility has been lower than the market average.

Beta (5Y) 0.84
52-Week Price Change +135.12%
50-Day Moving Average 11.28
200-Day Moving Average 8.07
Relative Strength Index (RSI) 80.59
Average Volume (20 Days) 3,370,005

Short Selling Information

The latest short interest is 8.99 million, so 4.92% of the outstanding shares have been sold short.

Short Interest 8.99M
Short Previous Month 8.03M
Short % of Shares Out 4.92%
Short % of Float 5.09%
Short Ratio (days to cover) 3.80

Income Statement

In the last 12 months, XERS had revenue of $368.26 million and -$6.50 million in losses. Loss per share was -$0.04.

Revenue368.26M
Gross Profit 321.80M
Operating Income 46.78M
Pretax Income -6.50M
Net Income -6.50M
EBITDA 58.94M
EBIT 46.78M
Loss Per Share -$0.04
Full Income Statement

Balance Sheet

The company has $131.08 million in cash and $226.07 million in debt, with a net cash position of -$94.98 million or -$0.52 per share.

Cash & Cash Equivalents 131.08M
Total Debt 226.07M
Net Cash -94.98M
Net Cash Per Share -$0.52
Equity (Book Value) 48.78M
Book Value Per Share 0.27
Working Capital 154.79M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $73.65 million and capital expenditures -$1.03 million, giving a free cash flow of $72.62 million.

Operating Cash Flow 73.65M
Capital Expenditures -1.03M
Depreciation & Amortization 12.16M
Net Borrowing -23.07M
Free Cash Flow 72.62M
FCF Per Share $0.40
Full Cash Flow Statement

Margins

Gross margin is 87.38%, with operating and profit margins of 12.70% and -1.76%.

Gross Margin 87.38%
Operating Margin 12.70%
Pretax Margin -1.76%
Profit Margin -1.76%
EBITDA Margin 16.00%
EBIT Margin 12.70%
FCF Margin 19.72%

Dividends & Yields

XERS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -10.49%
Shareholder Yield -10.49%
Earnings Yield -0.22%
FCF Yield 2.39%

Analyst Forecast

The average price target for XERS is $17.29, which is 3.35% higher than the current price. The consensus rating is "Strong Buy".

Price Target $17.29
Price Target Difference 3.35%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (3Y) 30.01%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

XERS has an Altman Z-Score of 1.41 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.41
Piotroski F-Score 7